Ozempic And Wegovy, Once Europe’s Crown Jewels, Now Facing Their Demons
Copycat drugs, tariffs, US competitors, and insurance coverage headaches are throwing off a once-thriving EU weight-loss market and its Danish crown jewel, Novo Nordisk. In early May, Novo Nordisk’s C